$2.50 +0.04 (1.63%) Vical Inc - NASDAQ

Dec. 9, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 2.50
Trade Time: Dec 09 04:00 PM Eastern Daylight Time
Change: +0.04 (1.63%)
Prev Close: 2.46
Open: 2.49
Bid: 2.44
Ask: 2.50
  1. No results found.
  1. CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores

    GuruFocus | Jan. 18, 2016 | 10:07AM EST
  2. Vical Posts Q1 Net Loss

    Benzinga | May. 8, 2015 | 06:51AM EST
  3. US Stock Futures Slip; JPMorgan Earnings In Focus

    Benzinga | Jan. 14, 2015 | 07:01AM EST
  4. US Stock Futures Edge Higher Ahead Of Retail Sales, Jobless Claims Data

    Benzinga | Dec. 11, 2014 | 07:01AM EST
  5. Vical Completes Enrollment In Its Therapeutic HSV-2 Vaccine Clinical Trial

    Benzinga | Dec. 11, 2014 | 06:32AM EST
  6. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  7. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 17:25PM EST
  8. John Rogers Comments on Vical

    GuruFocus | Feb. 26, 2014 | 15:10PM EST
  9. Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes

    Benzinga | Dec. 17, 2013 | 07:05AM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 16, 2013 | 10:35AM EST
  11. Kids Decide on Dolls or Devices - JAKK, Others 70% Off

    GuruFocus | Sep. 17, 2013 | 18:39PM EST
  12. UPDATE: Citigroup Lowers PT on Vical on Near-Term Challenges

    Benzinga | Aug. 14, 2013 | 09:37AM EST
  13. UPDATE: Credit Suisse Downgrades Vical Following Allovectin Program Termination

    Benzinga | Aug. 13, 2013 | 09:21AM EST
  14. UPDATE: Canaccord Genuity Downgrades Vical Following Allovectin Failure

    Benzinga | Aug. 13, 2013 | 08:32AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Aug. 13, 2013 | 06:48AM EST
Trading Center